Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Change in Account Payables (2016 - 2021)

Guided Therapeutics (GTHP) has disclosed Change in Account Payables for 11 consecutive years, with -$84000.0 as the latest value for Q2 2021.

  • Quarterly Change in Account Payables fell 197.67% to -$84000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was -$446000.0 through Jun 2021, down 4560.0% year-over-year, with the annual reading at -$372000.0 for FY2020, 1960.0% down from the prior year.
  • Change in Account Payables hit -$84000.0 in Q2 2021 for Guided Therapeutics, down from $29000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $148000.0 in Q1 2017 to a low of -$208000.0 in Q3 2020.
  • Historically, Change in Account Payables has averaged $388.89 across 5 years, with a median of $20500.0 in 2018.
  • Biggest five-year swings in Change in Account Payables: soared 353.33% in 2019 and later plummeted 730.3% in 2020.
  • Year by year, Change in Account Payables stood at $54000.0 in 2017, then decreased by 22.22% to $42000.0 in 2018, then crashed by 200.0% to -$42000.0 in 2019, then plummeted by 335.71% to -$183000.0 in 2020, then soared by 54.1% to -$84000.0 in 2021.
  • Business Quant data shows Change in Account Payables for GTHP at -$84000.0 in Q2 2021, $29000.0 in Q1 2021, and -$183000.0 in Q4 2020.